OptimizeRx Sales Momentum Continues with Two New Enterprise-level Engagements Added to its Digital Health Platform
One win represents a new platform client and the other the transition of a legacy client to the company’s new enterprise solution suite. The two deals have on average an annual contract value of
“These wins demonstrate the exceptional capabilities and reach of our solutions and their proven ability to deliver value to our clients,” said
“As pharma continues to see restricted travel and limited patient access to healthcare providers due to COVID-19, our platform has become a ‘must-have’ solution for maintaining the flow of critical communications between industry and healthcare providers regardless of location.”
OptimizeRx’s newly integrated digital health platform enables unprecedented transparency into patient medication behavior, and provides access to patient-provider-pharma communications across the care continuum and in a variety of care settings. By improving these communications, pharmaceutical companies, healthcare providers and payers can more efficiently and effectively address patient medication affordability and therapeutic adherence.
“Our up-sell opportunity for converting just our legacy clients from individual solutions to enterprise platform engagements remains greater than
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Tel (754) 245-7070
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation